Easterly Investment Partners LLC lessened its holdings in shares of Centene Co. (NYSE:CNC – Free Report) by 2.5% in the second quarter, according to its most recent filing with the SEC. The firm owned 144,961 shares of the company’s stock after selling 3,648 shares during the quarter. Easterly Investment Partners LLC’s holdings in Centene were worth $9,611,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in CNC. Rise Advisors LLC acquired a new stake in shares of Centene in the first quarter valued at $25,000. Riverview Trust Co lifted its holdings in shares of Centene by 154.6% in the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after buying an additional 320 shares during the period. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Centene in the second quarter valued at $36,000. Neo Ivy Capital Management acquired a new stake in shares of Centene in the fourth quarter valued at $40,000. Finally, Versant Capital Management Inc lifted its holdings in shares of Centene by 265.3% in the second quarter. Versant Capital Management Inc now owns 632 shares of the company’s stock valued at $42,000 after buying an additional 459 shares during the period. Institutional investors and hedge funds own 93.63% of the company’s stock.
Centene Stock Up 0.4 %
CNC stock traded up $0.32 during mid-day trading on Friday, hitting $78.55. The stock had a trading volume of 2,123,166 shares, compared to its average volume of 3,459,605. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.64. Centene Co. has a 1-year low of $60.83 and a 1-year high of $81.42. The company has a fifty day moving average of $71.02 and a 200 day moving average of $73.86. The stock has a market capitalization of $41.92 billion, a price-to-earnings ratio of 15.62, a PEG ratio of 1.00 and a beta of 0.50.
Analyst Ratings Changes
CNC has been the subject of several research analyst reports. TD Cowen upped their price objective on Centene from $80.00 to $89.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Jefferies Financial Group downgraded Centene from a “buy” rating to a “hold” rating and reduced their target price for the company from $83.00 to $69.00 in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft upped their target price on Centene from $82.00 to $87.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 target price on shares of Centene in a report on Monday, August 19th. Finally, Stephens reaffirmed an “equal weight” rating and set a $78.00 target price on shares of Centene in a report on Monday, August 5th. Nine investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and an average price target of $83.93.
Get Our Latest Stock Analysis on Centene
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- 3 Fintech Stocks With Good 2021 Prospects
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- What Are Some of the Best Large-Cap Stocks to Buy?
- MarketBeat Week in Review – 8/19 – 8/23
- 10 Best Airline Stocks to Buy
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.